网站地图
  校外导师
当前位置: 首页->研究生教育->校外导师->正文

杜丽娜

时间:2017年06月21日    来源:    作者:    阅读:

1.个人信息(Personals):

  女,1977.06,药剂学博士,硕士研究生导师,副研究员。曾获中国药学会青年药剂学奖,军队科技进步三等奖。世中联经皮给药专业委员会理事,国家自然科学基金评审专家,北京市自然科学基金评审专家。河南大学、安徽医科大学硕士生导师。已发表国内外文章78篇(包括40篇SCI论文)。获3项发明专利证书。Email:dulinachina@163.com。

2. 受教育经历 (Educational Experience) (从大学本科开始,按时间倒排序):

  2001/8–2006/6, 军事医学科学院, 药剂学, 博士, 导师:梅兴国

  1996/9–2000/6, 山东中医药大学, 中药学, 学士, 导师:田景振

3. 工作经历(Professional Experience)(按时间倒排序):

  2013/9-至今,军事医学科学院,放射与辐射医学研究所,副研究员

  2006/7-2013/8,军事医学科学院,放射与辐射医学研究所,助理研究员

  2000/7-2001/7,济南西郊医院,药剂科,药师

4. 研究兴趣(Research Interests):

  经皮肤、黏膜新型药物递送系统,脑靶向新型药物递送系统,军事药学

  5、承担项目情况(Financial Supports)(包括项目名称,批准号,金额,起止年月,基金来源,本人角色)

  1)基于经络穴位理论治疗哮喘的新型经皮给药系统,81441095,10万元,2015/01-2015/12,国家自然科学基金应急管理项目,主持

  2)抗HIV新药胆固醇基磷酰齐多夫定的研究,2012ZX09103101-059,国家科技重大专项“重大新药创制”, 135.57万元,2012/01-2015/12,主持

  3)多重肝靶向抗肿瘤自组装前药纳米给药系统,81202464,24万元,2013/01-2015/12,国家自然科学基金青年科学基金项目,主持

  4)综合性新药研究开发技术大平台-制剂技术平台,2009ZX09301-002,70万元,2008/10-2010/12,国家科技重大专项“重大新药创制”,主要参与

6. 代表性论著(Publications)

  期刊论文(Journal Articles) :所有作者(通讯作者以“*”标出),论文标题,期刊名称,卷(期), pp起始页码,发表年份

  1)Lina Du, Junwei Jia, Pingju Ge, Yiguang Jin*. Self-assemblies of 5'-cholesteryl-ethyl-phosphoryl zidovudine. Colloids and Surfaces B: Biointerfaces, 2016, 148:385-391 (2015 IF=3.902)

  2)Lina Du, Baolei Zhang, Youjie Lei, Shan Wang, Yiguang Jin*. Long-circulating and liver-targeted nanoassemblies of cyclic phosphoryl N-dodecanoyl gemcitabine for the treatment of hepatocellular carcinoma. Biomedicine & Pharmacotherapy, 2016, 79: 208-214. (2015 IF=2.326)

  3)Lina Du, Xue Feng, Xiaoqin Xiang, Yiguang Jin*. Wound healing effect of an in situ forming hydrogel loading curcumin-phospholipid complex. Current Drug Delivery, 2016, 13:76-82 (2015 IF=1.446).

  4)Xiang Yu#, Lina Du#, Lifei Zhu, Xiaoyan Liu, Baolei Zhang, Guiying Fu*,  Yiguang Jin*. Melanoma therapy with transdermal mitoxantrone cubic phases. Drug Delivery, 2016, 23(5):1565-1570, (2015 IF=4.843)# The two authors contributed equally.

  5)Xin Li#, Lina Du#, Xu Chen, Pingju Ge, Yu Wang, Yangmu Fu, Haiyan Sun, Qingwei Jiang*, Yiguang Jin*. Nasal delivery of analgesic ketorolac tromethamine thermo- and ion-sensitive in situ hydrogels. Int J Pharm, 2015, 489:252-260. (2015 IF=3.994) # The two authors contributed equally

  6)Lina Du, Lailong Wu, Yiguang Jin*, Junwei Jia, Miao Li, Yu Wang. Self-assembled drug delivery systems. Part 7: Hepatocyte-targeted nanoassemblies of an adefovir lipid derivative with cytochrome P450-triggered drug release. Int J Pharm, 2014,472:1-9. (2014 IF=3.65)

  7)Yunbo Sun#, Lina Du#, Yangpu Liu, Xin Li, Miao Li, Yiguang Jin*, Xiaohong Qian. Transdermal delivery of the in-situ hydrogels of curcumin and its inclusion complexes of hydroxypropyl-β-cyclodextrin for melanoma treatment. Int J Pharm, 2014, 469:31-39. (2014 IF=3.65) # The two authors contributed equally.

  8)Lina Du, Guanglong Li, Yiguang Jin*, Lin Wang, Qishou Xu, Junxing Dong*. Riboflavin laurate nanosuspensions as an intramuscular injection for long-term riboflavin supplementation. Int J Pharm, 2013, 450(1-2):338-344. (2013 IF=3.785)

  9)Lina Du, Yiguang Jin*, Jiangyong Yang, Shuangmiao Wang, Xiangtao Wang. A functionalized poly(amidoamine) nanocarrier loading 5-fluorouracil: pH-responsive drug release and enhanced anticancer effect. Anti-cancer Drugs, 2013, 24(2):172-180. (2013 IF=1.891)

  10)Lina Du, Li Tong, Yiguang Jin*, Junwei Jia, Yangpu Liu, Chang Su, Shanjiang Yu, Xin Li. A multifunctional in situ-forming hydrogel for wound healing. Wound Repair and Regeneration, 2012, 20(6):904-910. (2012 IF=2.757)

  11)Lina Du, Xingguo Mei, Chenyun Wang, Xin Li, Fucheng Zhang, Yiguang Jin*. In vitro / in vivo studies of the biodegradable poly(d,l-lactide-co-glycolide) microspheres of a novel luteinizing hormone-releasing hormone antagonist for prostate cancer treatment. Anti-cancer Drugs, 2011, 22(3): 262-272. (2011 IF=2.376)

  12)Lina Du, Yiguang Jin*, Wenying Zhou, Jingyu Zhao. Ultrasound-triggered drug release and enhanced anticancer effect of doxorubicin-loaded poly(lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanodroplets. Ultrasound Med Biol, 2011, 37(8): 1252-1258. (2011 IF=2.493)

  13)Lina Du, Miao Li, Yiguang Jin*. Determination of triclosan in antiperspirant gels by the first-order derivative spectrophotometry. Pharmazie, 2011, 66(10): 740-743. (2011 IF=1.006)

  14)Lina Du, Junping Cheng, Qiang Chi, Jiankun Qie, Yan liu, Xingguo Mei*. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist. Chem Pharm Bull, 2006, 54(9): 1259-1265. (2006 IF=1.262)

  15)Lifei Zhu, Xiaoyan Liu, Lina Du*, Yiguang Jin*. Preparation of asiaticoside-loaded coaxially electrospinning nanofibers and their effect on deep partial-thickness burn injury. Biomedicine & Pharmacology, 2016, 83: 33-40 (2015 IF=2.326)

  16)Jing Zuo, Lina Du*, Miao Li, Boming Liu, Weinan Zhu, Yiguang Jin*. Transdermal enhancement effect and mechanism of iontophoresis for non-steroidal anti-inflammatory drugs. Int J Pharm, 2014, 466:76-82. (2014 IF=3.65)

  17)Xin Li, Qingwei Jiang, Lina Du*, Ying Li, Miao Li. Evaluation of the novel immediate- / controlled-release tablets of isosorbide-5-mononitrate (5-ISMN): in vitro-in vivo correlation. Pharmazie, 2014, 69(2):109-116. (2014 IF=1.052)

  18)Xin Li, Qingwei Jiang, Lina Du*, Chenyun Wang, Qiang Chi. In vitro and in vivo evaluation of the novel osmotic pump tablets of isosorbide-5-mononitrate containing polyvinyl pyrrolidone (PVP) for controlled release. Pharmazie, 2012, 67(8):695-700 (2012 IF=0.962)

  19)Xin Li, Lina Du*, Chenyun Wang. Validation of LC/MS/MS method for quantitation of a new gastroprokinetic agent SHR116958 and its metabolite in rat plasma. Pharmazie, 2011, 66(11): 826-830. (2011 IF=1.006)

  20)Jing Zuo, Li Tong, Lina Du, Ming Yang, Yiguang Jin*. Biomimetic nanoassemblies of 1-O-octodecyl-2-conjugated linoleoyl-sn-glycero-3-phosphatidyl gemcitabine with phospholipase A2-triggered degradation for the treatment of cancer. Colloids and Surfaces B: Biointerfaces, 2017,152:467-474 (2015 IF=3.902).

  21)Lifei Zhu#, Miao Li#, Xiaoyan Liu, Lina Du, Yiguang Jin*. Inhalable oridonin-loaded poly(lactic-co-glycolic) acid large porous microparticles for in situ treatment of primary non-small cell lung cancer. Acta Pharmaceutica Sinica B, 2017,7(1):78-88

  22)Yiguang Jin*, Lina Du, Miao Li. Self-assembled drug delivery systems: the art of prodrug, molecular self-assembly and nanotechnology. Nanomedicine: Nanotechnology, Biology and Medicine, 2016, 12(2): 550-550. (2015 IF=5.671)

  23)Pingju Ge, Fugeng Sheng, Yiguang Jin*, Li Tong, Lina Du, Lei Zhang, Ning Tian, Gongjie Li*. Magnetic resonance imaging of osteosarcoma using a bis(alendronate)-based bone-targeted contrast agent. Biomedicine & Pharmacotherapy, 2016, 84:423-429 (2015 IF=2.326)

  24)Miao Li, Lifei Zhu, Boming Liu, Lina Du, Xiaodong Jia, Li Han*, Yiguang Jin*. Tea tree oil nanoemulsions for inhalation therapies of bacterial and fungal pneumonia. Colloids and Surfaces B: Biointerfaces, 2016, 141: 408-416 (2015 IF=3.902).

  25)Yiguang Jin*, Shan Wang, Weishang Yao, Lina Du. Molecular self-assembly of amphiphilic cyclic phosphoryl gemcitabine with different N-fatty acyl tails and enhanced anticancer effects of the self-assembled nanostructures. Colloids and Surfaces B: Biointerfaces, 2015, 133:356-361 (2014 IF=4.152).

  26)Xiang Yu, Lina Du, Yu Li, Guiying Fu, Yiguang Jin*. Improved anti-melanoma effect of a transdermal mitoxantrone. Biomedicine & Pharmacotherapy, 2015, 73: 6-11. (2014 IF=2.023)

  27)Yiguang Jin*, Xiaohan Zhang, Baolei Zhang, Hongxiang Kang, Lina Du, Miao Li. Nanostructures of an amphiphilic zinc phthalocyanine polymerconjugate for photodynamic therapy of psoriasis. Colloids and Surface B: Biointerfaces, 2015, 128:405-409 (2014 IF=4.152)

  28)Yiguang Jin,* Shuangmiao Wang, Li Tong*, Lina Du. Rational design of didodecyldimethylammonium bromide-based nanoassemblies for gene delivery. Colloid Surf B:Biointerfaces, 2015, 126:257-264 (2014 IF=4.152)

  29)Wei Gong, Rui Ma, Danyu Mei, Pei Jing, Xiao Dong, Bingsheng Li, Yanfang Yang, Lina Du, Xing-guo Mei*, Fu-qiang Hu. A novel subcutaneous infusion delivery system based on osmotic pump: in vitro and in vivo evaluation. Drug Delivery, 2014, 21(1):1-7. (2014 IF=2.558)

  30)Yangmu Fu, Qiang Zhang, Yong Sun, Weixiong Liao, Xiaowei Bai, Lili Zhang,  Lina Du, Yiguang Jin, Qi Wang, Zhongli Li, Yan Wang*. Controlled-release of bone morphogenetic protein-2 from a microsphere coating applied to acid-etched Ti6AL4V implants increases biological bone growth in vivo. J Orthop Res, 2014, 32(6): 744-751. (2014 IF=2.986)

  31)Yiguang Jin*, Weishang Yao, Lailong Wu, Lina Du. Langmuir monolayers of N-acyl derivatives of adefovir phosphonateat the air/water interface and molecular self-assembly in water. Colloids and Surfaces A: Physicochem. Eng Aspects, 2014, 462: 231–236 (2014 IF=2.752).

  32)Yiguang Jin*, Fang Yang, Lina Du. Nanoassemblies containing a fluorouracil/zidovudine glycerylprodrug with phospholipase A2-triggered drug release for cancer treatment. Colloids and Surfaces B: Biointerfaces, 2013, 112: 421- 428. (2013 IF=4.287)

  33)Yingzheng Zhao*, Lina Du, Cuitao Lu, Yiguang Jin, Shuping Ge. Potential and problems in ultrasound-responsive drug delivery system. International Journal of Nanomedicine, 2013, 8:1621-1633. (2013 IF=4.195)

  34)Yangmu Fu, Lina Du, Qi Wang, Weixiong Liao, Yiguang Jin, Anjie Dong, Chen Chen, Zhongli Li*. In vitro sustained release of recombinant human bone morphogenetic protein-2 microspheres embedded in thermosensitive hydrogels. Pharmazie, 2012, 67(4):299-303. (2012 IF=0.962)

  35)Yiguang Jin*, Yanju Lian, Lina Du, Shuangmiao Wang, Chang Su, Chunsheng Gao. Self-assembled drug delivery systems. Part 6: In vitro/in vivo studies of anticancer N-octadecanoyl gemcitabine nanoassemblies. Int J Pharm, 2012, 430: 276-281. (2012 IF=3.458)

  36)Yiguang Jin*, Yanju Lian, Lina Du. Self-assembly of N-acyl derivatives of gemcitabine at the air/water interface and the formation of nanoscale structures in water. Colloid Surface A, 2012, 393: 60-65. (2012 IF=2.108)

  37)Yiguang Jin*, Rui Xin, Li Tong, Lina Du, Miao Li. Combination anti-HIV therapy with the self-assemblies of an asymmetric bolaamphiphilic zidovudine/didanosine prodrug. Mol Pharm, 2011, 8: 867-876. (2011 IF=4.782)

  38)Xin Li, Lina Du, Chenyun Wang, Yan Liu, Xingguo Mei, Yiguang Jin*. Highly efficient and lowly toxic docetaxel nanoemulsions for intravenous injection to animals. Pharmazie, 2011, 66(7): 479-483. (2011 IF=1.006)

  39)Yiguang Jin*, Xia Ren, Wei Wang, Lijing Ke, Erjuan Ning, Lina Du, Jeremy Bradshaw. A 5-fluorouracil-loaded pH-responsive dendrimer nanocarrier for tumor targeting. Int J Pharm, 2011, 420: 378-384. (2011 IF=3.35)

  40)Yiguang Jin*, Lei Xing, Ying Tian, Miao Li, Chunsheng Gao, Lina Du, Junxing Dong, Hongxuan Chen. Self-assembled drug delivery systems. Part 4. In vitro/in vivo studies of the self-assemblies of cholesteryl-phosphonyl zidovudine. Int J Pharm, 2009, 38: 40-48. (2009 IF=2.962)

  41)杜丽娜,金义光*. 脑靶向鼻黏膜给药系统用于神经退行性疾病治疗.国际药学研究杂志,2016,43(1):104-109

  42)杜丽娜,朱伟南,刘晓妍,陈文杨,于翔,李淼,金义光*. 防治哮喘用白芥子涂法复方巴布剂的制备及体内外研究.中国中药杂志,2014,39(23): 4596-4602

  43)杜丽娜,刘笑,贾俊伟,韩光,金义光*. 离子导入对阿魏酸透皮吸收的促进作用. 国际药学研究杂志,2014,41(5):530-534

  44)杜丽娜,李淼,苏畅,田瑛,刘思杨,金义光*.抗HIV药物胆固醇基磷酰齐多夫定的自组装体的体外药效学评价. 国际药学研究杂志,2013,40(1): 69-72.

  45)杜丽娜,金义光*.抗HIV巨噬细胞靶向给药系统的研究进展.国际药学研究杂志,2013,40(1):39-42.

  46)杜丽娜,金义光*.经皮给药系统研究进展.国际药学研究杂志,2013, 40(4):379-385.杜丽娜,姚静,苏畅,金义光*. 抗菌纳米银原位凝胶的制备和体外药效评价. 国际药学研究杂志,2011,38(2):153-156.

  47)杜丽娜, 李淼,李欣,屈国乐,金义光*.微乳法制备阿昔洛韦固体脂质纳米粒.中国药物应用与检测,2011,8(4):207-210.

  48)杜丽娜,张文明,金义光*.布洛芬肠溶微囊的研制.医学研究杂志,2011,40(9):58-61.

  49)杜丽娜,苏畅,施沅坤,金义光*. 用于战伤急救的聚维酮碘原位凝胶的制备与评价.解放军药学学报,2010,26(6):471-474.

  50)王辰允#,杜丽娜#,周文英,程志刚,金义光*.载阿霉素超声敏感纳米泡的制备与性质.中国医院药学杂志,2010,30(2):97-99.(#为共同第一作者)

  51)杜丽娜,郭庆东,刘 燕,梅兴国*. 牛血清白蛋白-PLGA微球制备的单因素考察.中国药业,2005,14(5):49-50

  52)杜丽娜,王辰允,梅兴国*. 用SPSS软件计算微球平均粒径及粒径分布范围. 数理医药学杂志,2005,18(2):159-163.

  53)杜丽娜,艾国,梅兴国*. 生物技术药物口服微粒给药系统的研究进展.中国新药杂志,2005,14(1):18-23.

  54)杜丽娜,梅兴国*. Caco-2细胞模型在药物吸收研究中的应用.中国中医药信息杂志,2005,12(Suppl):14-17

  55)杜丽娜,梅兴国*. 口服基因治疗的创新:挑战与前景.中国药物应用与监测,2004,1(2):19-21.

  56)马山,孙金杰,王欣,李淼,杜丽娜*,田景振*.杜仲乙醇提取物对脑老化模型小鼠血中氧化应激指标的影响.国际药学研究杂志,2016,43(5):922-925

  57)李欣,丁亚琼,丁晶,杜丽娜*,金义光*.多西他赛纳米泡的制备和性质.国际药学研究杂志, 2016,43(5):956-960

  58)刘晓妍,朱李飞,杜丽娜*,金义光*.积雪草总苷同轴和混纺纳米纤维膜的制备和缓释性能评价. 国际药学研究杂志,2016,43(2):330-335

  59)左靖,杨明,李淼,杜丽娜*,金义光*.吉西他滨脂质衍生物聚合物胶束的制备、理化性质和抗肿瘤活性. 中国药理学与毒理学杂志,2014,28(3):408-414.

  60)汪珊,杜丽娜*,佟丽,李淼,金义光*,韩光. 磷酰-N-十四酰吉西他滨脂质衍生物自组装体的制备、性质和抗肿瘤作用. 国际药学研究杂志,2014,41(2):149-154.

  61)白毅,杜丽娜*,冯雪,金义光*. 天然药物经皮给药系统研究进展.中国药学杂志,2014,49(16):1377-1381.

  62)化玮,杜丽娜*.药物开发软件Catalyst 及其在计算机辅助药物设计中的应用. 北京联合大学学报(自然科学版),2011,25(1):28-33

  63)张伟莉,吴志鸿*,杜丽娜,王群,于佳,金义光*.姜黄素壳聚糖脂质体治疗兔角膜碱烧伤. 国际药学研究杂志,2016,43(4):705-710

  64)陈丽娟,鲁翠涛,赵应征,杜丽娜,金义光*. 超声微泡用于脑胶质瘤靶向药物递送. 药学学报,2015,50(1):99-103.

  65)向晓琴,杜丽娜,冯雪,金义光*. 冬凌草甲素粉雾剂的制备及其对大鼠急性肺损伤的治疗. 国际药学研究杂志,2014,41(2):211-215.

  66)徐清波,丁晓然,杜丽娜,鲁丹丹,金义光,王升启*. 透膜肽修饰的载流感泰得PLGA纳米粒的制备与评价. 军事医学,2014,38(7):518-522.

  67)李秋,李淼,金义光*,杜丽娜,苏畅,董俊兴. 载紫杉醇pH敏感嵌段共聚物胶束的制备和体外药效.国际药学研究杂志,2013,40(2): 233-236.

  68)龚伟, 杨阳, 金义光, 杜丽娜, 张慧, 梅兴国*. 新型药物递送系统研究进展. 中国科学:生命科学,2011,41(10):894-903.

  69)王双苗,杨江勇,杜丽娜,金义光*,周兰兰*.载氟尿嘧啶pH敏感树枝状聚合物纳米载体的体外释药及对人肝癌细胞药效学评价.国际药学研究杂志,2011,38(2):148-152

  70)李欣,姜庆伟*,杜丽娜. 单硝酸异山梨酯控释片的制备及在Beagle犬体内生物利用度研究.解放军药学学报,2011,27(1):11-13+16.

  71)李欣*,杜丽娜.盐酸阿夫唑嗪缓释片的人体生物等效性研究.解放军药学学报,2011,27(2):132-134.

  72)王辰允,刘燕,杜丽娜,黄世杰,梅兴国*.肠舒通胶囊的药效学研究.中国医院用药评价与分析,2009,9(12):922-924.

  73)迟强,许鹏,杜丽娜,卢山,栾中山*,徐珺洋,王黎黎,杨志.胸腺五肽乙酯的抗应激作用研究.医学研究杂志,2009,38(11):70-73.

  74)迟强,杜丽娜,刘燕,梅兴国*,刘芬. LHRH拮抗剂-CMC复合物的鉴别及含量测定.解放军药学学报,2008,24(3):221-223

  75)邢磊,金义光*,陈洪轩,杜丽娜. 齐多夫定脂质前药自组装体的制备及其在大鼠血浆中的稳定性. 国际药学研究杂志,2008,35(3):161-164.

  76)艾国,杜丽娜,梅兴国*. 蛋白质、多肽类药物新剂型与新技术发展动态.中国生化药物杂志,2004,25(6):366-369.

  77)钟凡,杜丽娜. 应用Maple和Matlab进行生化工程建模实践. 计算机与应用化学,2003,20(3):291-294.

  78)刘燕,杜丽娜,艾国,梅兴国*. 蛋白质多肽类药物给药系统的研究进展.药学前沿,2003:90-102.

  论著(Books):所有作者,专著名称(章节标题),出版社, 总字数,出版年份

  1)杜丽娜副主编. 纳米技术在药物递送中的应用.金义光主编. 北京:化学工业出版社,2015.4

  2)杜丽娜副主编.生物药物制剂学.赵应征主编.杭州:浙江大学出版社,2011.6

  3)杜丽娜参编.药品食品冷冻干燥手册.张福成主编.北京:军事医学科学出版社,2011.4

  4)杜丽娜参编.超声介导药物靶向递送系统.赵应征主编.北京:化学工业出版社,2010.7

  5)杜丽娜参编. 微载体药物递送系统.梅兴国主编.武汉:华中科技大学出版社,2009.11

  6)杜丽娜副主译. 药物传递-原理与应用. 金义光主译. 北京:化学工业出版社,2008.2

  7)杜丽娜参编. 药物新剂型与制剂新技术.梅兴国主编. 北京:化学工业出版社,2007.1

  8)杜丽娜参编. 治疗指南:精神病分册. 赵志刚主编. 北京:化学工业出版社,2006.4

  9)杜丽娜参编. 生物技术药物制剂-基础与应用. 梅兴国主编. 北京:化学工业出版社,2004.10

7. 专利(Patents):发明人,专利名称,授权时间,授权国别,专利号

  1)金义光,杜丽娜,邢磊,辛瑞. 胆固醇基磷酰核苷类似物,2009.2,中国,专利号 ZL 200610112295.7

  2)金义光,杜丽娜,陈书峰. 异烟肼脂质衍生物及其组合物,2012.9,中国,专利号ZL 2008 1 0166863.0

  3)金义光,杜丽娜,苏畅. 战创伤敷料组合物,2013.2, 中国,专利号ZL 201010047977.0

8. 奖励(Awards):所有获奖人,获奖项目名称,奖励机构,奖励类别,奖励等级,颁奖年份

  迟强,许鹏,卢山,栾中山,杜丽娜,徐君洋,杨志.多肽药物长效注射剂,原中国人民解放军总后勤部,军队科技进步奖,三等奖,2011.12.2,5/7

9.其他类:根据个人情况自由填写

  1)2015年获中国药学会青年药剂学奖

  2)2015.9.10 获长治医学院优秀教师

  3)获得2016年《国际药学研究杂志》优秀审稿专家

  4)“脑靶向鼻黏膜给药系统用于神经退行性疾病治疗”获2016年度“国际药学研究杂志”优秀论文

  5)“制备载积雪草苷同轴载药纳米纤维膜治疗深II度烧伤”获世界中医药学会联合会经皮给药专业委员会成立大会暨第一届学术年会会议论文集二等奖,2015.10.24-25,北京

  6) “一种新型抗HIV自组装体-胆固醇基磷酰齐多夫定乙酯的体内外研究”获第十二届全国青年药学工作者最新科研成果交流会优秀论文三等奖,2014.6,南京

  7)“多功能原位凝胶用于放射性皮肤损伤的研究”获第九届全军辐射医学专业委员会学术会议优秀论文,2011.8.25-8.27,西宁